/Investor DB

Sinopharm Capital

Seed–Late Stage

Find your way into Sinopharm Capital

Sign up to see every warm intro you have to Sinopharm Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sinopharm Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit
Stage
Seed–Late Stage
Tracked investments
1
Acquisitions
1

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Semma Therapeuticssemma-tx.comNov 2017acquired by Vertex Pharmaceuticals · Sep 2019 · $950M

Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.

BiotechCambridge, US

Robert Millman(Executive Officer, Director)

BoardTodd Foley(Executive Officer, Director)inMitch Finer(Director)Stephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)

Co-investorsARCH Venture PartnersF-Prime CapitalJDRF T1D FundORI CapitalSlater Technology Fund6 Dimensions Capital+4 more

Exits · 1

1 acquisitions

Semma Therapeuticsacq. by Vertex Pharmaceuticals

Frequently asked questions

What stage does Sinopharm Capital invest at?
Sinopharm Capital invests at the Seed, Late Stage stages.

Similar investors

Featured in lists